ASND earnings call for the period ending December 31, 2018.
News & Analysis: Ascendis Pharma
Find out how these stocks climbed in a down market.
A proprietary extended-release drug-delivery technology may be worth a lot more than anyone expected.
ASND earnings call for the period ending September 30, 2018.
ASND earnings call for the period ending June 30, 2018.
These stocks climbed despite a mixed market. Find out why.
One biopharma's loss is another biopharma's gain when it comes to rare disease drug trials.